KICVentures Group portfolio company AxioMed achieved Patent For Lateral Lumbar Viscoelastic Disc Replacement Medical Device
there is a sense of urgency in commercializing the AxioMed cervical, lumbar and lateral lumbar viscoelastic disc replacements internationally
MALDEN, Massachusetts (PRWEB) September 18, 2021
AxioMed continues to press its advantages in the artificial total disc replacement market with its investment in lateral lumbar viscoelastic disc technology. At a time when revenues and margins are driving the spine industry, AxioMed chose to venture alone into developing a lateral lumbar viscoelastic disc replacement.
We thank the United States Patent and Trademark Office (USPTO) for recognizing this unique, differentiated viscoelastic disc replacement technology and giving us their approval for this patent.
KICVentures Group CEO and Board-Certified Orthopedic Spine Surgeon and Professor Dr. Kingsley R. Chin says “there is a sense of urgency in commercializing the AxioMed cervical, lumbar and lateral lumbar viscoelastic disc replacements internationally”.
About AxioMed
AxioMed was founded in 2001 by surgeons at Cleveland Clinic and engineers who previously worked with Dr. Art Steffee and Acroflex viscoelastic disc replacement. The current AxioMed disc comprises of a proprietary silica-based viscoelastic material proven in extensive biomedical/biocompatible testing to mimic the human disc in all planes and 50+ years of longevity testing. The viscoelastic material is radiolucent and thus X-ray and MRI compatible. Over 800 discs have been implanted worldwide with zero failures or revisions. It is the only viscoelastic lumbar disc to complete a USA IDE clinical study with 10+ years of follow-up.
http://www.AxioMed.com
Om KICVentures Group
Grundlagt i 2000 gør os til det mest erfarne holdingselskab for sundhedsinvesteringer med den største portefølje af medicinsk udstyrsteknologier fokuseret på løsninger til mindre invasiv ambulant rygsøjlekirurgi. Vores investeringsstrategi er at erhverve eller opfinde disruptive teknologier ved hjælp af vores egen kapital eller partner med private individuelle investorer. Dette giver os friheden til at træffe hurtige og smidige beslutninger, som da vi købte AxioMed Viscoelastic Disc Technologies, mens andre firmaer investerede i kugle-og-socket artikulerende afstandsstykker.
http://www.KICVenturesGroup.com
Del artiklen om sociale medier eller e-mail: